Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C De Mey

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
MMW Fortschritte Der Medizin|November 10, 2000
[Evidence-based trial confirms: phytotherapeutic drug protects veins]C de Mey
British Journal of Clinical Pharmacology|May 1, 1995
Method specificity of the auscultatory estimates of the inodilatory reduction of diastolic blood pressure based on Korotkoff IV and V criteriaC De Mey
Medizinische Klinik (Munich, Germany : 1983)|February 11, 2000
[Sense and nonsense of post-authorization surveillance]C de Mey
European Urology|September 11, 1998
Cardiovascular effects of alpha-blockers used for the treatment of symptomatic BPH: impact on safety and well-beingC de Mey
European Urology|September 11, 1998
Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPHC de Mey
Clinical Pharmacology and Therapeutics|July 1, 1997
Reliability of screening procedures in identifying subjects suitable for enrollment in clinical pharmacology studiesC de Mey
International Journal of Clinical Pharmacology and Therapeutics|December 1, 1994
Analysis of pharmacokinetic-dynamic interrelations with special reference to applications in cardiovascular clinical pharmacologyC de Mey
International Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Inverse PK/PD: estimation and differentiation of bioavailability from effect kinetics--observations with beta-adrenoceptor antagonistsC De Mey
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Sense and nonsense in post-authorization surveillance]C de Mey
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1997
Hemodynamic surrogate end-points in phase I studies?C De Mey
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
MMW Fortschritte Der Medizin|November 10, 2000
[Evidence-based trial confirms: phytotherapeutic drug protects veins]C de Mey
British Journal of Clinical Pharmacology|May 1, 1995
Method specificity of the auscultatory estimates of the inodilatory reduction of diastolic blood pressure based on Korotkoff IV and V criteriaC De Mey
Medizinische Klinik (Munich, Germany : 1983)|February 11, 2000
[Sense and nonsense of post-authorization surveillance]C de Mey
European Urology|September 11, 1998
Cardiovascular effects of alpha-blockers used for the treatment of symptomatic BPH: impact on safety and well-beingC de Mey
European Urology|September 11, 1998
Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPHC de Mey
Clinical Pharmacology and Therapeutics|July 1, 1997
Reliability of screening procedures in identifying subjects suitable for enrollment in clinical pharmacology studiesC de Mey
International Journal of Clinical Pharmacology and Therapeutics|December 1, 1994
Analysis of pharmacokinetic-dynamic interrelations with special reference to applications in cardiovascular clinical pharmacologyC de Mey
International Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Inverse PK/PD: estimation and differentiation of bioavailability from effect kinetics--observations with beta-adrenoceptor antagonistsC De Mey
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Sense and nonsense in post-authorization surveillance]C de Mey
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1997
Hemodynamic surrogate end-points in phase I studies?C De Mey
Pageof 12